The 2024 Nobel Prizes in physics and chemistry were seen as a sweep for artificial intelligence (AI) tools which, at their ...

Bank stocks largely boosted the Dow, as investors hope the sector could see weaker regulation in a second Trump ...

A growing body of research describes seasonal trends in psychiatric disorders, with conditions like depression, schizophrenia ...

Mental illnesses are on the rise in Pakistan, pointing to a crisis that has to be addressed on a larger scale Concern over ...

However, he warned that there was "schizophrenia" in the bond market ... A 145-year-old British industrial company is ...

“Maybe I am from another planet,” I told my friend who first suggested the idea.

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Brady: Let me just follow up with one quick thing I think about, which is the demographic trends in this country and others ...

Shares of AbbVie (ABBV) are sinking on Monday after the company said two mid-stage trials of its investigative treatment for adults with schizophrenia missed their primary endpoints. AbbVie’s ...

AbbVie (ABBV) shares dropped 11% premarket as late-stage trials for schizophrenia drug emraclidine did not meet primary ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the third quarter of 2024, along with recent product highlights and corporate ...